The Kable

Home
Friday Kable
Features
About
💉 Novartis shells out the big bucks; From Africa for Africa; A new weapon against malaria?
#515 | Feeling hot, hot, hot; A mix that has more than just spice; Obesity and European kids
 • 
Vinod
1

April 2024

💉Mpox becomes stronger, brace for impact; Malaria comes for the world, vaccines be damned; The world gets hungrier
#514 | MSF says clinical trials cost way less than industry makes it out to be; Hep A surges in Colombia; Birds fly everywhere
 • 
Vinod
💉Africa CDC says Moderna is abandoning commitments; Nigeria rolls out a new meningitis vaccine; Cough syrups come for Africa
#513 | A new weapon against cholera; The WHO defines air-borne illnesses; The US says it will prevent the next pandemic
 • 
Vinod
1
💉Merck digs deeper into ADCs; Vertex boosts immunology pipeline; J&J buys Shockwave
#512 | Heat alert for East Asia; AI for Africa; Vaccine for UTIs
 • 
Vinod
💉Gingko Bio becomes Gingko Buyo; Ipsen enters the ADC race; Bird flu enters the conversation, again
#511 | A clinical trial for Lassa fever; A polio vaccine shortage for India; New hope against autoimmune conditions
 • 
Vinod
3

March 2024

💉AbbVie gets into colitis, Novo Nordisk digs deeper into cardio, Go West! To Pharmaconex
#510 | Guess who's back? It's dengue; Guess who never went away? It's mpox; AI designs antibodies
 • 
Vinod
💉 AstraZeneca puts in $2 billion on radiopharma; Novo goes big in China; Merck bets big on Korea
#509 | Novartis' big aims for Singapore; AbbVie bets on IBD; A future without babies
 • 
Vinod
2
💉 AstraZeneca invests in rare diseases; Novartis hopes to take the STING out; Merck bets on smart biologics
#508 | Bird flu jumps species; Ending the gender gap in wifi; Milk for diabetes
 • 
Vinod
💉 The APTF comes a step closer to fruition; Cervical cancer gets a lot of money; Africa unites against malaria
#507 | Merck sets up distribution centre in Brazil; Walking is good for your heart; The Arctic loses its ice
 • 
Vinod
1
💉 Gingko goes shopping, and doesn't stop; The WHO says the world eats too much glop; Live near a McD's? Stop!
#506 | Takeda to make dengue vaccine in India; SK bio gets WHO prequalification for typhoid shot; IVI sets up shop in Rwanda
 • 
Vinod

February 2024

💉 The new big pharma market; Big bucks queue up for Sanofi arm; Novavax makes a settlement
#505 | Hair loss drug to solve heart woes; GSK says injectable better than pills for HIV treatment
 • 
Vinod
💉 Gilead bets on liver disease; EFTA bats for extended IP; Is long Covid really real?
#504 | The US FDA love affair with Indian manufacturing continues
 • 
Vinod
© 2024 The Kable
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture